Pa. Judge Rescinds Accutane Mass Tort Status, Sends Cases To 'Day Forward' Program

PHILADELPHIA - A Pennsylvania state judge on Sept. 24 granted Hoffman-La Roche Inc.'s motion to rescind the designation of 20 cases involving the acne drugs Accutane and isotretinoin as mass torts and to transfer them to the court's Day Forward Program (In Re: Accutane/Isotretinoin Litigation, June Term, 2011, Case ID 110601110, Pa. Comm. Pls., Philadelphia Co.). View related prior history, 2012 U.S. Dist. LEXIS 6370.

Access this news story on®